Search

Dong Hak An

from Placentia, CA
Age ~80
Get Report
Also known as:
Dong H An, Hak An Dong, Doug H An, Dong Hak, Dong H Ann, An Dong Hak, Don An, Dong Han, Don Han
Phone and address:
161 E Orangethorpe Ave SPC 34, Placentia, CA 92870
Related to:
Jin S An, 52Jime H Kim, 50Sharon H Lee, 50Jeena J Han, 67Joong K Han, 71Lee Do, 66Jin W Lee, 42Dohoon Lee, 50Mi Ja An, 72Jiyeon LeeEun Ha Lee, 52Phillip S An, 47Glen LeeH Andong
Connected to:
Alex An, 37Alice T An, 47Annie S An, 73Boi T An, 58Byoung K An, 62Claire C An, 74Dae H An, 54Dira An, 43Fei An, 67Haejung An, 66

Dong An Phones & Addresses

  • 161 E Orangethorpe Ave SPC 34, Placentia, CA 92870
  • 16191 Tunisia Cir, Placentia, CA 92870 (714) 528-6600
  • 17949 Paseo Valle, Chino Hills, CA 91709 (714) 226-0900
  • Fullerton, CA
  • 2843 W Academy Ave, Anaheim, CA 92804 (714) 745-7771
  • Los Angeles, CA
  • Santa Ana, CA
  • San Bernardino, CA
  • Orange, CA

Work

Company: Black legend capital management - Los Angeles, CA Jun 2014 Position: Analyst intern

Education

School / High School: University of California- Davis, CA 2013 Specialities: Master of Business Administration in Finance

Resumes

Resumes

Dong An Photo 1

Dong An

View page
Dong An Photo 2

Dong An

View page
Dong An Photo 3

Dong An Davis, CA

View page
Work:
Black Legend Capital Management
Los Angeles, CA
Jun 2014 to Aug 2014
Analyst Intern
Shanghai Purang Financial Service Co. Ltd

Jan 2013 to Sep 2013
Brokerage Department Manager
Shanghai CFETS-ICAP International Money Broking Co. Ltd

Jan 2010 to Dec 2012
Broker
Shanghai Purang Financial Service Co. Ltd

Jun 2008 to Sep 2008
Sales Intern
China Minsheng Banking Corp. Ltd
Suzhou, CN
Jun 2007 to Sep 2007
Credit Risk Intern
Education:
University of California
Davis, CA
2013 to 2015
Master of Business Administration in Finance
Aston University
Birmingham
Jun 2009
Bachelor in Business Administration and Political Science

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dong An
Owner
Orotech U S A
Whol Jewelry/Precious Stones
955 S New Hampshire Ave, Los Angeles, CA 90006
(213) 623-7655
Dong An
President
Kam Hua Trading LTD Co
Women's and Misses' Blouses and Shirts
1147 Wall St #101, Los Angeles, CA 90015
(213) 747-5438
Dong H. An
Owner
Oxford Jewelry
Ret Jewelry
745 S Oxford Ave, Los Angeles, CA 90005
(213) 386-7310
Dong An
President
HUA SHENGSHUN INVESTMENT, INC
767 N Hl St #208, Los Angeles, CA 90012
Dong S. An
President
GO-STOP, INC
332 E 11 St, Los Angeles, CA 90015
Dong S. An
President
DNJ, INC
1880 S Wood Ct, La Habra, CA 90631

Publications

Us Patents

Method For Expression Of Small Antiviral Rna Molecules Within A Cell

View page
US Patent:
7732207, Jun 8, 2010
Filed:
Mar 21, 2007
Appl. No.:
11/689407
Inventors:
Xiao-Feng Qin - Pasadena CA, US
David Baltimore - Pasadena CA, US
Dong Sung An - Los Angeles CA, US
Assignee:
California Institute of Technology - Pasadena CA
The Regents of the University of California - Oakland CA
International Classification:
C12Q 1/68
C12P 19/34
C12N 15/87
C07H 21/02
C07H 21/04
US Classification:
435465, 435 6, 435 911, 4353201, 435457, 435475, 435489, 536 231, 536 2432, 536 245
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). The methods can be used to express double stranded RNA complexes. Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell, that interfere with a viral life cycle by down regulating either the viral genome, a viral genome transcript, or a host cell that. In another aspect the invention provides methods for treating patients having suffering from infection, particularly infection with HIV. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle.

Method For Expression Of Small Antiviral Rna Molecules With Reduced Cytotoxicity Within A Cell

View page
US Patent:
7737124, Jun 15, 2010
Filed:
Mar 8, 2007
Appl. No.:
11/683962
Inventors:
David Baltimore - Pasadena CA, US
Xiao-Feng Qin - Pasadena CA, US
Dong Sung An - Los Angeles CA, US
Assignee:
California Institute of Technology - Pasadena CA
The Regents of the University of California - Oakland CA
International Classification:
A01N 43/04
C12Q 1/68
C12P 19/34
C12N 15/00
C07H 21/04
US Classification:
514 44, 435 6, 435 911, 435 9131, 4353201, 435455, 536 231, 536 243, 536 245
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.

Method For Expression Of Small Antiviral Rna Molecules Within A Cell

View page
US Patent:
7919309, Apr 5, 2011
Filed:
Sep 13, 2002
Appl. No.:
10/243553
Inventors:
David Baltimore - Pasadena CA, US
Xiao-Feng Qin - Pasadena CA, US
Dong Sung An - Los Angeles CA, US
Assignee:
California Institute of Technology - Pasadena CA
International Classification:
C12N 15/00
C12N 15/88
C12Q 1/68
C12P 19/34
C07H 21/04
US Classification:
4353201, 435 6, 435 911, 435 9131, 435455, 536 231, 536 2431, 536 245
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector. The methods can be used to express double stranded RNA complexes. Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell, that interfere with a viral life cycle by down regulating either the viral genome, a viral genome transcript, or a host cell that. In another aspect the invention provides methods for treating patients having suffering from infection, particularly infection with HIV.

Method For Expression Of Small Antiviral Rna Molecules With Reduced Cytotoxicity Within A Cell

View page
US Patent:
8361982, Jan 29, 2013
Filed:
Apr 28, 2010
Appl. No.:
12/769157
Inventors:
David Baltimore - Pasadena CA, US
Xiao-Feng Qin - Pasadena CA, US
Dong Sung An - Los Angeles CA, US
Assignee:
California Institute of Technology - Pasadena CA
The Regents of the University of California - Oakland CA
International Classification:
A01N 43/04
C12Q 1/68
C12N 15/00
C12P 19/34
C07H 21/04
US Classification:
514 44, 435 6, 435 911, 435 9131, 4353201, 435455, 536 231, 536 243, 536 245
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.

Dual Vector For Inhibition Of Human Immunodeficiency Virus

View page
US Patent:
20120201794, Aug 9, 2012
Filed:
May 26, 2010
Appl. No.:
13/384206
Inventors:
Irvin Chen - Palos Verdes Estates CA, US
Dong Sung An - Los Angeles CA, US
Michelle L. Millington - Hornsby Heights, AU
Maureen P. Boyd - North Ryde, AU
Geoffrey P. Symonds - Rose Bay, AU
Louis Randall Breton - Tucson AZ, US
Assignee:
Calimmune Inc. - Tucson AZ
International Classification:
A61K 31/713
C12N 15/86
A61P 31/18
C12N 5/10
A61K 35/14
C12N 15/85
C12N 15/867
US Classification:
424 9321, 4353201, 435325, 514 44 R
Abstract:
The present invention provides an expression vector for preventing or inhibiting HIV entry, fusion or replication in mammalian cells. In particular, the invention provides a recombinant retroviral vector that encodes an inhibitor of a HIV co-receptor, such as CCR5 or CXCR4, and a protein that inhibits HIV fusion to target cells and/or HIV replication. Pharmaceutical compositions comprising such constructs and methods of use thereof to prevent or treat HIV infection in a patient are also disclosed.

Method For Expression Of Small Antiviral Rna Molecules With Reduced Cytotoxicity Within A Cell

View page
US Patent:
20130295615, Nov 7, 2013
Filed:
Jan 24, 2013
Appl. No.:
13/749319
Inventors:
Xiao-Feng Qin - Sugarland TX, US
Irvin S.Y. Chen - Palos Verdes Estates CA, US
Dong Sung An - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
California Institute of Technology - Pasadena CA
International Classification:
C12N 15/113
US Classification:
435 9132, 4353201
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.

Method For Expression Of Small Antiviral Rna Molecules With Reduced Cytotoxicity Within A Cell

View page
US Patent:
20190002883, Jan 3, 2019
Filed:
Jul 5, 2018
Appl. No.:
16/028262
Inventors:
- Pasadena CA, US
- Oakland CA, US
Xiao-Feng Qin - Sugarland TX, US
Irvin S.Y. Chen - Palos Verdes Estates CA, US
Dong Sung An - Los Angeles CA, US
International Classification:
C12N 15/113
C12N 15/11
C12N 15/63
C12N 15/86
A61K 48/00
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.

Method For Expression Of Small Antiviral Rna Molecules With Reduced Cytotoxicity Within A Cell

View page
US Patent:
20170107519, Apr 20, 2017
Filed:
Dec 30, 2016
Appl. No.:
15/395348
Inventors:
- Pasadena CA, US
- Oakland CA, US
Xiao-Feng Qin - Sugarland TX, US
Irvin S.Y. Chen - Palos Verdes Estates CA, US
Dong Sung An - Los Angeles CA, US
International Classification:
C12N 15/113
C12N 15/11
C12N 15/86
Abstract:
In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.
Control profile
Dong Hak An from Placentia, CA, age ~80 Get Report